Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4827-4836. doi: 10.1210/jc.2019-00022.
Accurate diagnosis of adrenal insufficiency is critical because there are risks associated with overdiagnosis and underdiagnosis. Data using liquid chromatography tandem mass spectrometry (LC/MS/MS) free cortisol (FC) assays in states of high or low cortisol-binding globulin (CBG) levels, including cirrhosis, critical illness, and oral estrogen use, are needed.
Cross-sectional.
Determine the relationship between CBG and albumin as well as total cortisol (TC) and FC in states of normal and abnormal CBG. Establish the FC level by LC/MS/MS that best predicts TC of <18 μg/dL (497 nmol/L) (standard adrenal insufficiency diagnostic cutoff) in healthy individuals.
This study included a total of 338 subjects in four groups: healthy control (HC) subjects (n = 243), patients with cirrhosis (n = 38), intensive care unit patients (ICU) (n = 26), and oral contraceptive (OCP) users (n = 31).
MAIN OUTCOME MEASURE(S): FC and TC by LC/MS/MS, albumin by spectrophotometry, and CBG by ELISA.
TC correlated with FC in the ICU (R = 0.91), HC (R = 0.90), cirrhosis (R = 0.86), and OCP (R = 0.70) groups (all P < 0.0001). In receiver operator curve analysis in the HC group, FC of 0.9 μg/dL (24.8 nmol/L) predicted TC of <18 μg/dL (497 nmol/L; 98% sensitivity, 91% specificity; AUC, 0.98; P < 0.0001). Decreasing the cutoff to 0.7 μg/dL led to a small decrease in sensitivity (92%) with similar specificity (91%).
A cutoff FC of <0.9 μg/dL (25 nmol/L) in this LC/MS/MS assay predicts TC of <18 μg/dL (497 nmol/L) with excellent sensitivity and specificity. This FC cutoff may be helpful in ruling out adrenal insufficiency in patients with binding globulin derangements.
准确诊断肾上腺功能不全至关重要,因为过度诊断和漏诊都存在风险。需要使用液相色谱串联质谱(LC/MS/MS)游离皮质醇(FC)检测方法,检测高或低皮质醇结合球蛋白(CBG)水平状态下(包括肝硬化、危重病和口服雌激素使用)的数据。
横断面研究。
确定 CBG 与白蛋白以及正常和异常 CBG 状态下总皮质醇(TC)和 FC 之间的关系。通过 LC/MS/MS 确定 FC 水平,以最佳预测健康个体 TC <18μg/dL(497nmol/L)(标准肾上腺功能不全诊断截止值)。
这项研究共包括 338 名受试者,分为 4 组:健康对照组(HC)受试者(n=243)、肝硬化患者(n=38)、重症监护病房(ICU)患者(n=26)和口服避孕药(OCP)使用者(n=31)。
LC/MS/MS 检测的 FC 和 TC、分光光度法检测的白蛋白和 ELISA 检测的 CBG。
TC 与 ICU(R=0.91)、HC(R=0.90)、肝硬化(R=0.86)和 OCP(R=0.70)组的 FC 相关(均 P<0.0001)。在 HC 组的受试者工作特征曲线分析中,FC 为 0.9μg/dL(24.8nmol/L)预测 TC <18μg/dL(497nmol/L;98%敏感性,91%特异性;AUC,0.98;P<0.0001)。将截止值降低至 0.7μg/dL 会导致敏感性(92%)略有下降,但特异性(91%)相似。
该 LC/MS/MS 检测中 FC<0.9μg/dL(25nmol/L)的截止值可准确预测 TC <18μg/dL(497nmol/L),具有良好的敏感性和特异性。该 FC 截止值可能有助于排除结合球蛋白紊乱患者的肾上腺功能不全。